Sign up for free insights newsletter
Coloplast A/S

Coloplast A/S

COLO-BNasdaq Copenhagen

Need professional-grade analysis? Visit stockanalysis.com

DKK 426.80
-4.33%
End of day
Market Cap

$101.84B

P/E Ratio

25.56

Employees

16,983

Dividend Yield

5.07%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.76-2.75-2.13-1.85-1.84-2.02
Calmar-14.75-6.06-2.37-1.50-0.97-2.99
Sharpe-4.41-2.59-1.89-1.53-1.51-1.93
Omega0.000.400.570.710.730.60
Martin-24.04-11.64-4.45-3.65-1.88-5.65
Ulcer4.046.6113.9011.6320.6313.91

Coloplast A/S (COLO-B) Price Performance

Coloplast A/S (COLO-B) trades on Nasdaq Copenhagen in DKK. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at DKK426.80, down 4.33% from the previous close.

Over the past year, COLO-B has traded between a low of DKK426.80 and a high of DKK713.54. The stock has lost 39.1% over this period. It is currently 40.2% below its 52-week high.

Coloplast A/S has a market capitalization of $101.84B, with a price-to-earnings ratio of 25.56 and a dividend yield of 5.07%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Company Info

Exchange
Nasdaq Copenhagen
Currency
DKK
Country
Denmark

Financial Metrics

Revenue (TTM)
$27.89B
EBITDA
$8.58B
Profit Margin
14.30%
EPS (TTM)
17.68
Book Value
61.31

Technical Indicators

52 Week High
DKK 719.31
52 Week Low
DKK 422.30
50 Day MA
DKK 511.17
200 Day MA
DKK 572.65
Beta
0.55

Valuation

Trailing P/E
25.56
Forward P/E
17.76
Price/Sales
3.65
Price/Book
7.30
Enterprise Value
$126.15B